Scientists grow eye cells to fix corneas

April 17, 2017 by Lisa M. Krieger, The Mercury News
Credit: CC0 Public Domain

A Stanford University research team has created a potentially powerful new way to fix damaged corneas—a major source of vision problems and blindness.

Millions of new eye cells are being grown in a Palo Alto lab, enlisting one of medicine's most important and promising new tools: refurbishing diseased and damaged tissue with healthy new cells.

"One of the exciting possibilities of this cellular approach is that one donor cornea," which contributes a few parent cells, "can generate enough cells to treat tens or hundreds of patients," said lead researcher Dr. Jeffrey Goldberg, professor and chairman of the Department of Ophthalmology at the Stanford School of Medicine.

About 100,000 corneal transplants are done annually in the United States - but they require surgery with donated corneas from cadavers. The procedure fails nearly a third of the time, and there aren't enough high-quality donor corneas to go around.

Other scientists have been trying to grow full corneas from scratch, attaching a fragile film of cells to a membrane. That's a challenging bioengineering problem.

Stanford's innovative strategy, eight years in the making, is to grow instead. The team then harvests a few "mother" , called , donated from a cadaver.

Those cells are then put into a warm broth in petri dishes, where they give birth to many new corneal cells.

The Stanford team enlisted a recent technological advance: magnetic nanoparticles. The particles are very small, measuring only 50 nanometers in diameter. In comparison, a human hair is 75,000 nanometers in diameter.

The new cells were magnetized with the nanoparticles, loaded into a syringe and injected into the eye. Then, using an electromagnetic force on a patch held outside of the eye, the team pulled the cells into the middle of the eye, to the back of cornea. Later, the magnetic nanoparticles fell off the cells, exited the eye and were excreted in the patients' urine.

Ultimately, Goldberg said, the team hopes to mass produce "off-the-shelf" cells that can be easily transplanted into patients with severe damage to the cornea, the transparent outer coating of the eye that covers the iris and pupil.

In the first trial of 11 patients, a so-called Phase 1 trial, the team studied only safety. Not only was the procedure safe, but "we are seeing hints of efficacy that we are very excited about," Goldberg said. "We're cautiously optimistic."

The Stanford team plans to expand the study in September to Phase 2 to measure how the vision of the patients improves.

The approach is part of an expanding field of lab-grown cell therapies. Sheets of healthy skin are used to treat burns, chronic skin wounds and diseases like epidermolysis bullosa, which causes incurable blistering. And "bioengineered" cartilage is increasingly used to treat certain knee injuries.

Stanford researchers believe that lab-grown corneal could become another important type of regenerative medicine.

Unlike other transplants, corneas in the Stanford team's approach don't have to be a perfect "match." Rejection can be prevented with topical eyedrops.

While relatively few people in the United States suffer diseases or injuries that cause devastating cornea damage, the numbers are much greater in developing nations, where infectious eye diseases remain common.

The new approach could offer a nonsurgical permanent solution in those countries, Goldberg said.

"Half the world has no access to tissue," he said. "I would love this to be 'one and done,' solving patients' problems for decades."

Explore further: Curing blindness by repairing corneas with invisible films

33 shares

Related Stories

Curing blindness by repairing corneas with invisible films

August 15, 2016
A patented treatment could restore eyesight for millions of sufferers of corneal disease.

Researchers find proliferating cells in normal and diseased corneal endothelium

September 14, 2016
Researchers from Massachusetts Eye and Ear have, for the first time, identified rapidly proliferating cells (known as "neural crest-derived progenitor cells") in the corneal endothelium of specimens from normal corneas and ...

Wisdom teeth stem cells can transform into cells that could treat corneal scarring

February 23, 2015
Stem cells from the dental pulp of wisdom teeth can be coaxed to turn into cells of the eye's cornea and could one day be used to repair corneal scarring due to infection or injury, according to researchers at the University ...

Stem cells can repair a damaged cornea

March 5, 2012
A new cornea may be the only way to prevent a patient going blind – but there is a shortage of donated corneas and the queue for transplantation is long. Scientists at the Sahlgrenska Academy at the University of Gothenburg, ...

Researchers shed light on repair mechanism for severe corneal injuries

September 29, 2016
In cases of severe ocular trauma involving the cornea, wound healing occurs following intervention, but at the cost of opaque scar tissue formation and damaged vision. Recent research has shown that mesenchymal stem cells ...

Stem cells have potential to repair diseased corneas

September 18, 2014
Corneal transplant (keratoplasty) is a known means of successfully treating corneal disease. However, without unlimited donor corneas, researchers say there is a need to study alternate methods of treatment for eye disease ...

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.